Fantastic decision making by Vortiv management Talk about value destruction Share price down 20% at open Market is doing the talking It HATES this move HATES, HATES, HATES All management of Vortiv must RESIGN NOW!!
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status